250 LARODOPA ROCHE (Larodopa 250 MG)
Generic Name: levodopa
Pill with imprint 250 LARODOPA ROCHE is Pink, Round and has been identified as Larodopa 250 MG. It is supplied by Roche Laboratories.
Larodopa is used in the treatment of parkinson's disease; restless legs syndrome; periodic limb movement disorder and belongs to the drug class dopaminergic antiparkinsonism agents. FDA has not classified the drug for risk during pregnancy. Larodopa 250 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for 250 LARODOPA ROCHE
Larodopa
- Generic Name
- levodopa
- Imprint
- 250 LARODOPA ROCHE
- Strength
- 250 MG
- Color
- Pink
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roche Laboratories
- National Drug Code (NDC)
- 00004-0057
More about Larodopa (levodopa)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
Other brands: Inbrija
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
